The looming pandemic of COVID-19: What therapeutic options do we have now?
作者信息
Afsar Nasir Ali
机构信息
Jinnah Medical and Dental College, Sohail University, Karachi, Pakistan.
出版信息
J Chin Med Assoc. 2020 May;83(5):508-509. doi: 10.1097/JCMA.0000000000000310.
Abstract
摘要
相似文献
1
The looming pandemic of COVID-19: What therapeutic options do we have now?新冠疫情的逼近：我们目前有哪些治疗选择？
J Chin Med Assoc. 2020 May;83(5):508-509. doi: 10.1097/JCMA.0000000000000310.
2
COVID-19: Main therapeutic options.新型冠状病毒肺炎：主要治疗选择
Tunis Med. 2020 Apr;98(4):299-303.
3
Perspective on the COVID-19 Coronavirus Outbreak.关于新冠病毒疫情的观点。
Comb Chem High Throughput Screen. 2020;23(2):90-91. doi: 10.2174/138620732302200406130010.
4
COVID-19: Time for precision epidemiology.新型冠状病毒肺炎：精准流行病学时代来临。
Exp Biol Med (Maywood). 2020 Apr;245(8):677-679. doi: 10.1177/1535370220919349. Epub 2020 Apr 17.
5
Impact of coronavirus outbreak on psychological health.冠状病毒爆发对心理健康的影响。
J Glob Health. 2020 Jun;10(1):010331. doi: 10.7189/jogh.10.010331.
6
The COVID-19 pandemic.新冠疫情。
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S4-S6. doi: 10.5455/JPMA.02.
7
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为新型冠状病毒肺炎暴露后预防用药
N Engl J Med. 2020 Sep 10;383(11):1087-1088. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
8
SARS-CoV-2 pandemic and the need for transplant-oriented trials.严重急性呼吸综合征冠状病毒2型大流行与开展以移植为导向的试验的必要性。
Transpl Int. 2020 Aug;33(8):966-968. doi: 10.1111/tri.13626. Epub 2020 May 14.
9
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为新型冠状病毒肺炎暴露后预防用药
N Engl J Med. 2020 Sep 10;383(11):1088. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
10
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为新冠病毒暴露后预防用药
N Engl J Med. 2020 Sep 10;383(11):1088-1089. doi: 10.1056/NEJMc2023617. Epub 2020 Jul 15.
引用本文的文献
1
Severe acute respiratory syndrome coronavirus-2 and the deduction effect of angiotensin-converting enzyme 2 in pregnancy.严重急性呼吸综合征冠状病毒 2 与血管紧张素转换酶 2 在妊娠中的推断作用。
J Chin Med Assoc. 2020 Sep;83(9):812-816. doi: 10.1097/JCMA.0000000000000362.
本文引用的文献
1
Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study.基于众包数据的 2019 年冠状病毒病早期流行病学分析：人群水平观察研究。
Lancet Digit Health. 2020 Apr;2(4):e201-e208. doi: 10.1016/S2589-7500(20)30026-1. Epub 2020 Feb 20.
2
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.韩国第三代 COVID-19 感染传播者索引患者病例：应用洛匹那韦/利托那韦定量 RT-PCR 监测 COVID-19 感染肺炎的治疗。
J Korean Med Sci. 2020 Feb 17;35(6):e79. doi: 10.3346/jkms.2020.35.e79.
3
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.预防性和治疗性瑞德西韦（GS-5734）治疗中东呼吸综合征冠状病毒感染恒河猴模型。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.
4
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
5
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
6
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study.利巴韦林和干扰素治疗中东呼吸综合征危重症患者：一项多中心观察性研究。
Clin Infect Dis. 2020 Apr 15;70(9):1837-1844. doi: 10.1093/cid/ciz544.
7
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.糖皮质激素治疗中东呼吸综合征危重症患者。
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.
8
Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage.锌含片与普通感冒：一项比较醋酸锌和葡萄糖酸锌以及锌剂量作用的荟萃分析。
JRSM Open. 2017 May 2;8(5):2054270417694291. doi: 10.1177/2054270417694291. eCollection 2017 May.
9
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.洛匹那韦/利托那韦或干扰素-β1b治疗可改善普通狨猴中东呼吸综合征冠状病毒感染非人灵长类动物模型的预后。
J Infect Dis. 2015 Dec 15;212(12):1904-13. doi: 10.1093/infdis/jiv392. Epub 2015 Jul 21.
10
Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia.中东呼吸综合征冠状病毒（MERS-CoV）：沙特阿拉伯一家三级护理医院的病例报告。
Ann Saudi Med. 2014 Sep-Oct;34(5):396-400. doi: 10.5144/0256-4947.2014.396.
Zotero 插件